We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 162

Topic: Immunization financing

Page 4 of 9
Evaluating the Cost and Financing of National Immunization Programs

As new vaccines are introduced, accurate information on the cost and financing of national immunization programs can be lacking. This website is designed to serve as a hub for all new information on immunization costing and financing studies to help …

Author: Harvard T.H. Chan School of Public Health

Evaluation of Cost-Effectiveness of Live Oral Pentavalent Reassortant Rotavirus Vaccine Introduction in Ghana

This article, published in Vaccine, estimates the cost-effectiveness of introducing the rotavirus vaccine RotaTeq® in Ghana. The authors estimated the average costs of treating children with diarrhea in the Ashanti region of Ghana as inpatients and …

Author: Abbott C, Tiede B, Armah G, Mahmoud A

Publication date: 2012

The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): Data for Decision-Making Around PCV Use in Childhood

This report provides the latest information on pneumococcal conjugate vaccines (PCV) and their use in routine immunization programs around the world. It includes key background on the burden of pneumococcal disease in children and the impact of PCVs …

Author: International Vaccine Access Center

Publication date: 2017

Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-Effectiveness Analyses

This supplement to Vaccine contains 38 articles featuring country-led research to support real-time policymaking, including cost-effectiveness, program costing, and analyses of financial flows for vaccine introduction. It highlights work undertaken …

Author: Andrus JK, Walker DG, eds.

Publication date: 2015

An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China

This article, published in Vaccine, reports on a study to evaluate the cost-effectiveness of human papillomavirus (HPV) vaccination to prevent cervical cancer in China. The authors found that HPV is cost-effective across all income groups when the …

Author: Levin CE, Sharma M, Olson Z, et al.

Publication date: 2015

Financing Assessment Tool for Immunization Services: Guidelines for Performing a Country Assessment

On behalf of Partnerships for Health Reform, this immunization financing tool is intended for in-depth, systematic evaluations of the costs and financing of immunization programs. The tool offers a checklist and tables that guide the user through …

Author: Kaddar M, Makinen M, Khan M

Publication date: 2000

The Future of Global Immunization: Will the Promise of Vaccines be Fulfilled?

Childhood immunization is one of the most successful and cost-effective of all health interventions, especially for reducing infant and child morbidity and mortality globally. Still, nearly two million children die of vaccine-preventable deaths each …

Author: Cochi SL

Publication date: 2011

The Future of Immunisation Policy, Implementation, and Financing

The authors of this article, published in The Lancet, discuss the challenges and possibilities of further expanding coverage of existing vaccines while widely implementing new vaccines, with respect to low-income and middle-income countries. They …

Author: Levine OS, Bloom DE, Cherian T, et al.

Publication date: 2011

GAVI's Advance Market Commitment

This article, published in The Lancet, details how the GAVI Alliance's pilot Advance Market Commitment financing mechanism works to stimulate the manufacture of affordable pneumococcal vaccines for developing countries. ABSTRACT ONLY. (Learn how …

Author: Schwalbe N, El-Ziq I

Publication date: 2010


This website is a public search tool that provides open access to G-FINDER survey data. The G-FINDER survey tracks annual global investments into neglected disease product research and development, including vaccines. The tool allows easy creation …

Author: Policy Cures

Global Action Plan for Prevention and Control of Pneumonia

This document outlines a global action plan to support countries in controlling pneumonia, providing a framework for action around which partners can coordinate their efforts. The document summarizes the global situation with respect to pneumonia, …

Author: World Health Organization, United Nations Children's Fund

Publication date: 2009

Global Health Technologies Coalition

The Global Health Technologies Coalition's website highlights the coalition's work to advocate for the development of global health tools for the developing world. The website serves as a clearinghouse for information and resources on research …

Author: Global Heath Technologies Coalition

Global Pandemic Influenza Action Plan to Increase Vaccine Supply: Progress Report 2006 - 2008

This progress report is a follow on to the World Health Organization's (WHO's) Global Pandemic Influenza Action Plan (GAP) released in May 2005 to address the global shortage of influenza vaccines for epidemics and potential pandemics. It summarizes …

Author: World Health Organization

Publication date: 2009

Global Polio Eradication Initiative

The Global Polio Eradication Initiative is a public-private partnership led by national governments and spearheaded by the World Health Organization, Rotary International, the US Centers for Disease Control and Prevention, and the United Nations …

Author: Global Polio Eradication Initiative

Global Post-Eradication IPV Supply and Demand Assessment: Integrated Findings

This report summarizes the findings from a global post-eradication inactivated polio vaccine (IPV) supply and demand assessment conducted from 2007 to 2008. The goal of the study was to inform ongoing IPV discussions and potential policy development …

Author: Oliver Wyman, Inc.

Publication date: 2009

Global Vaccine Action Plan 2011-2020

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. The GVAP …

Author: World Health Organization

Publication date: 2012

Going for Goal: Immunisation and the Case for GAVI

Like the World Cup—with teams from six continents coming together to compete on a level playing field—the GAVI Alliance is also a story about the world coming together: different donors, countries, activists, technical partners, and private …

Author: The ONE Campaign

Publication date: 2014

Guidelines for Estimating the Economic Burden of Diarrheal Disease with Focus on Assessing the Costs of Rotavirus Diarrhea

WHO developed these guidelines to present a method for determining the costs associated with diarrheal disease in children under 5 years of age.

Author: World Health Organization

Publication date: 2005

Health Economics of Rotavirus Immunization in Vietnam: Potentials for Favorable Cost-Effectiveness in Developing Countries

This article, published in Vaccine, reports on a study designed to assess the cost-effectiveness of rotavirus immunization in Vietnam. It specifically focused on the use of RotaTeq® and assessing the affordability of implementing universal …

Author: Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ

Publication date: 2012

Health Systems and Immunization Financing for Human Papillomavirus Vaccine Introduction in Low-Resource Settings

This article, published in Vaccine, reports on a study that assessed health systems and immunization financing in order to offer recommendations for appropriate and effective strategies for human papillomavirus (HPV) vaccine delivery in low-resource …

Author: Biellik R, Levin C, Mugisha E, et al.

Publication date: 2009

Page 4 of 9